ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,446Medicare Part D Prescriptions Filled, Including Refills

Rank: 90 out of 973

$527K Total Retail Price of All Prescriptions

Rank: 127 out of 973

529 Patients Receiving at Least One Drug in Part D
64%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 529 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

29% of this provider’s 529 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

4% of this provider’s 7,507 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
SIMVASTATIN 641 442 1 1
HYDROCODONE-ACETAMINOPHEN 526 307 S3 2 4
FUROSEMIDE 468 313 3 6
AMLODIPINE BESYLATE 410 276 4 7
OMEPRAZOLE 353 212 5 5
POTASSIUM CHLORIDE 288 179 6 9
METFORMIN HCL 270 199 7 8
LISINOPRIL 263 195 8 3
LOSARTAN POTASSIUM 239 173 9 19
LEVOTHYROXINE SODIUM 226 155 10 2
CIPROFLOXACIN HCL 222 160 11 57
METOPROLOL SUCCINATE 212 150 12 17
CARVEDILOL 203 153 13 27
ALLOPURINOL 197 170 14 29
NEXIUM 193 108 15 30
GLIMEPIRIDE 188 154 16 41
MELOXICAM 177 107 17 23
METOPROLOL TARTRATE 176 132 18 13
KLOR-CON M20 159 91 19 64
GLYBURIDE 143 113 R 20 59
TRAMADOL HCL 132 62 21 18
ZOLPIDEM TARTRATE 132 99 21 20
HYDROCHLOROTHIAZIDE 126 71 23 11
LOSARTAN-HYDROCHLOROTHIAZIDE 117 95 24 46
CLONIDINE HCL 116 91 25 67
PROAIR HFA 109 41 26 54
CYCLOBENZAPRINE HCL 107 53 R 27 42
ATORVASTATIN CALCIUM 93 78 28 15
TAMSULOSIN HCL 89 79 29 28
CLOPIDOGREL 80 50 30 44
SINGULAIR 76 47 31 106
LEVOFLOXACIN 76 50 31 84
ISOSORBIDE MONONITRATE ER 75 43 33 85
ATENOLOL 72 36 34 16
LANTUS 69 51 35 39
GLIPIZIDE 67 38 36 69
GABAPENTIN 67 33 36 12
ALENDRONATE SODIUM 66 62 38 24
VENTOLIN HFA 64 28 39 180
FLUTICASONE PROPIONATE 64 23 39 35
AZITHROMYCIN 63 43 41 47
SERTRALINE HCL 57 42 42 21
WARFARIN SODIUM 56 30 43 10
INSULIN SYRINGE 56 33 43 153
CLOTRIMAZOLE-BETAMETHASONE 52 33 45 164
ADVAIR DISKUS 52 24 45 60
LANSOPRAZOLE 52 42 45 155
METHYLPREDNISOLONE 52 34 45 159
HYDROCORTISONE 51 33 49 221
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.